ABSTRACT Background and Aims Thalassemia is an inherited hemoglobin disorder characterized by ineffective erythropoiesis, chronic anemia, and progressive multisystem complications that require lifelong management. Current treatment relies on regular red blood cell transfusions, iron chelation therapy, and supportive multidisciplinary care, while ...
Fnu Zainab +3 more
wiley +1 more source
Distribution of Hemoglobin Variants: A Retrospective Study Based on Hemoglobin Electrophoresis Results From a University Hospital in Madagascar. [PDF]
Fenomanana J +6 more
europepmc +1 more source
Maternal and neonatal outcomes in Gaza amid armed hostilities in 2025
Abstract Objective This study documents facility‐based maternal, obstetric, and neonatal outcomes and associated conflict‐related exposures and living conditions among pregnancy‐related encounters at Al‐Helou Maternity Hospital in Gaza from late April to early September 2025, with a small number of additional encounters recorded at Al‐Shifa Medical ...
Shaymaa Abuhaiba +16 more
wiley +1 more source
Insights Into Hemoglobinopathies in Spain: A Comprehensive Review. [PDF]
Corrons JV.
europepmc +1 more source
Unstable Hemoglobin, a Rare but Significant Cause of Hemolytic Anemia: Recognition of Peripheral Smear Findings Is Crucial for Diagnosis. [PDF]
Shean RC, Agarwal A, Rets AV.
europepmc +1 more source
Genome Editing for Glycogen Storage Diseases
ABSTRACT Gene therapy has been developed for several glycogen storage diseases and has advanced into clinical trials. However, the limitations of these gene therapies with regard to stability following treatment early in life have led to the development of genome editing.
Troy von Beck +2 more
wiley +1 more source
Cerebral Blood Transit in Sickle Cell Anemia
ABSTRACT Background Sickle cell anemia (SCA) patients upregulate cerebral blood flow to compensate for decreased arterial oxygen content. Such hyperemic conditions can manifest as venous hyperintense signal on arterial spin labeling (ASL) MRI, which may reflect faster capillary blood transit, altered oxygen extraction fraction (OEF), and infarct risk ...
Wesley T. Richerson +10 more
wiley +1 more source
Emerging Technologies and Advanced Strategies in Hemoglobin Defect Screening. [PDF]
Zhang C, Chen VC, Osa-Andrews B, Cao J.
europepmc +1 more source
Smart Design: Integrating Artificial Intelligence and Gene Editing for Advanced mRNA Therapeutics
The challenges of mRNA therapy and the application of artificial intelligence and gene editing in the field of mRNA drugs. ABSTRACT Artificial intelligence (AI) and gene editing are increasingly being applied to the design and evaluation of mRNA therapeutics.
Haixing Shi +11 more
wiley +1 more source
Special Issue "Genetic Modifiers of Hemoglobinopathies: Recent Advances and Future Directions". [PDF]
Lederer CW, Felice AE, Kountouris P.
europepmc +1 more source

